The endocytic recycling regulator EHD1 is essential for spermatogenesis and male fertility in mice by Rainey, Mark A et al.
RESEARCH ARTICLE Open Access
The endocytic recycling regulator EHD1 is
essential for spermatogenesis and
male fertility in mice
Mark A Rainey
1, Manju George
1, GuoGuang Ying
2, Reiko Akakura
3, Daniel J Burgess
4, Ed Siefker
4, Tom Bargar
5,
Lynn Doglio
6, Susan E Crawford
7, Gordon L Todd
5, Venkatesh Govindarajan
4, Rex A Hess
8, Vimla Band
1,5,
Mayumi Naramura
1*, Hamid Band
1,5,9*
Abstract
Background: The C-terminal Eps15 homology domain-containing protein 1 (EHD1) is ubiquitously expressed and
regulates the endocytic trafficking and recycling of membrane components and several transmembrane receptors.
To elucidate the function of EHD1 in mammalian development, we generated Ehd1
-/- mice using a Cre/loxP
system.
Results: Both male and female Ehd1
-/- mice survived at sub-Mendelian ratios. A proportion of Ehd1
-/- mice were
viable and showed smaller size at birth, which continued into adulthood. Ehd1
-/- adult males were infertile and
displayed decreased testis size, whereas Ehd1
-/- females were fertile. In situ hybridization and immunohistochemistry
of developing wildtype mouse testes revealed EHD1 expression in most cells of the seminiferous epithelia.
Histopathology revealed abnormal spermatogenesis in the seminiferous tubules and the absence of mature
spermatozoa in the epididymides of Ehd1
-/- males. Seminiferous tubules showed disruption of the normal
spermatogenic cycle with abnormal acrosomal development on round spermatids, clumping of acrosomes,
misaligned spermatids and the absence of normal elongated spermatids in Ehd1
-/- males. Light and electron
microscopy analyses indicated that elongated spermatids were abnormally phagocytosed by Sertoli cells in Ehd1
-/-
mice.
Conclusions: Contrary to a previous report, these results demonstrate an important role for EHD1 in pre- and post-
natal development with a specific role in spermatogenesis.
Background
The C-terminal Eps15 homology domain-containing
(EHD) proteins regulate endocytic recycling of mem-
brane and associated cell surface receptors [1]. The
founding EHD family member, the single C. elegans
ortholog RME-1 (Receptor-Mediated Endocytosis-1),
was identified in a screen for mutants defective in yolk
protein endocytosis, and is required for yolk receptor
and basolateral fluid recycling in the worm [2]. Muta-
tions of the single Drosophila EHD protein ortholog
Past1 decreased fertility and germline development in
the fly [3]. Mammals express four highly homologous
EHD proteins (EHD1-4) each containing an N-terminal
ATPase domain [4,5], a central coiled-coil region that
facilitates homo- and hetero-oligomerization [6-8], and a
single C-terminal Eps15 homology (EH) domain that
mediates interactions with proteins containing Asn-Pro-
Phe motifs [9,10]. Ectopic expression of each human
EHD protein in C. elegans rme-1 mutants rescued the
basolateral recycling defect indicating a basic functional
similarity of human EHD proteins and RME-1 [7]. How-
ever, the presence of four EHD proteins in mammals
suggests tissue-specific and/or non-redundant roles of
individual family members.
The sorting of endocytosed receptors determines
whether they are recycled to the cell surface or degraded
in the lysosomes. Receptors destined for recycling are
trafficked through either a fast recycling pathway from
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pathway through the endocytic recycling compartment
(ERC) [11-13]. EHD proteins appear to regulate critical
nodes in the endocytic sorting/recycling process [14].
Several lines of evidence suggest that EHD1 regulates
the rate of ERC to cell surface trafficking in the slow
recycling pathway. Overexpression of a dominant-nega-
tive mouse EHD1 mutant (G429R) disrupted the mor-
phology of the ERC and slowed the exit of transferrin
from the ERC [15]. Knock-down of EHD1 using siRNA
delayed the release of transferrin and decreased surface
levels of b1 integrin due to reduced recycling from the
ERC [16]. Co-overexpression studies demonstrated that
recycling of the major histocompatibility complex
(MHC) class I molecule H-2D
d from an intracellular
compartment to the cell surface was increased with
EHD1 overexpression [17] and EHD1 depletion led to
retention of MHC class I in a compact pericentriolar
compartment reminiscent of the ERC [18]. EHD1 also
maintains the perinuclear localization of glucose trans-
porter 4 in cultured adipocytes [19] and positively regu-
lates the kinetics of endosome-to-Golgi retrieval of the
cation-independent mannose-6-phosphate receptor [20].
We previously suggested that EHD4 regulates the EE
to ERC transport of transferrin based on siRNA-
mediated depletion of EHD4 [7]. In support of this
hypothesis, EHD4 depletion led to retention of recy-
cling-destined transferrin or MHC class I and lyso-
some-destined low-density lipoproteins in enlarged
EEs, suggesting that EHD4 regulates the rate of exit of
trafficking receptors from the EEs towards both the
ERC and lysosomal degradation routes [8]. In neuronal
cells, EHD4 (also known as Pincher) also mediates for-
mation of clathrin-independent macroendosomes of
TrkA and TrkB receptor tyrosine kinases [21].
EHD3 has been ascribed two distinct roles in regulating
t h ee x i to ft r a f f i cf r o mt h eE E st ob o t ht h eE R C[ 2 2 ]a n d
the Golgi [23]. EHD3 depletion led to fragmentation of
the Golgi [23]. Although less studied, EHD2 has been
ascribed a role in endocytosis [24], nucleotide-dependent
membrane remodeling [5] and fusion of myoblasts [25].
To date, studies of the EHD protein family have lar-
gely focused on their role in trafficking transferrin and
receptors using in vitro assays. In contrast to in vitro
studies implicating mammalian EHD proteins in the
regulation of endocytic recycling, the only evidence for
their in vivo roles is by analogy to RME-1 in C. elegans
and Past1 in Drosophila. Direct evidence for an in vivo
function of EHD proteins in mammalian systems is pre-
sently lacking. Analyses of the expression of EHD para-
logs in different mouse tissues are consistent with the
likelihood that different EHD proteins may have tissue-
specific as well as more redundant roles [7]. Early stu-
dies highlighted the relatively high Ehd1 mRNA and
protein expression in mouse testis (human EHD1 is also
known as Testilin [GenBank: AF099011]), kidney, heart,
intestine and brain [9]. In the same study, immunohisto-
chemistry revealed EHD1 protein expression in elon-
gated spermatids in the testis, adipocytes, lung, heart
and specific retinal layers in mice [9]. EHD1 has also
been found in exosome-like vesicles purified from the
cauda epididymal fluid of rams [26]. Contrary to expec-
tations based on a relatively high expression in certain
organs, targeted deletion of the EHD1 C-terminal region
in mice did not produce an overt phenotype [27]. Given
the plethora of in vitro cell biological studies supporting
a role for mammalian EHD1, we used a different target-
ing strategy to generate an Ehd1 knockout mouse that
completely lacks EHD1 expression and assessed whether
the loss of EHD1 had any demonstrable impact on adult
organ function. In contrast to previous results [27], we
report that Ehd1-null mice survive at sub-Mendelian
ratios in several mouse strains, display reduced growth
as compared to wildtype (WT) mice and Ehd1
-/- males
are infertile. We conclude that the endocytic recycling
regulator EHD1 plays an important role in mouse devel-
opment and is essential for male fertility. To our knowl-
e d g e ,t h i si st h ef i r s tk n o c k o u tm o u s em o d e lo fm a l e
infertility due to the loss of a single protein implicated
in endocytic recycling.
Results
Generation of EHD1-deficient mice
EHD1-deficient mice were generated using a recombineer-
ing strategy as described in Methods (Figure 1A). PCR
analysis of tail DNA confirmed the Ehd1 gene was cor-
rectly targeted in heterozygous deleted (Ehd1
+/-), homozy-
gous deleted (Ehd1
-/-), heterozygous floxed (Ehd1
fl-Neo/+),
and homozygous floxed (Ehd1
fl-Neo/fl-Neo)m i c e( F i g u r e1 B ) .
RT-PCR also confirmed the absence of Ehd1 mRNA in
the testis of Ehd1
-/- male mice (Figure 1C).
Previously, we showed that EHD proteins were
expressed in several mouse organs in both male and
female mice [7]. Western blots performed on lysates of
mouse organs obtained from WT, Ehd1
+/- and Ehd1
-/-
mice confirmed that disruption of Ehd1 led to a loss of
EHD1 protein expression in Ehd1
-/- male (Figure 2) as
well as female mice (data not shown). Intermediate
levels of EHD1 were seen in the lung, kidney, heart,
spleen, and testis of Ehd1
+/- mice when compared to
WT and Ehd1
-/- mice (Figure 2). These results demon-
strated that the targeting strategy led to complete loss
of EHD1 expression in Ehd1
-/- mouse tissues.
Deletion of Ehd1 in different mouse strains results in
partial lethality
Crosses of Ehd1
+/- mice on a 129;B6 mixed background
did not produce the expected Mendelian ratio of Ehd1
-/-
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Page 2 of 19Figure 1 Generation of Ehd1
-/- mice using Cre/loxP-mediated genetic recombineering. (A) A partial restriction map of the Ehd1 locus, the
targeting vector and the mutated Ehd1 loci. The first exon was deleted by Cre/loxP-mediated recombination. Black rectangles represent exons,
grey and white triangles represent loxP and FRT sequences, respectively. H, HindIII; RI, EcoRI. (B) DNA was prepared from mouse tails for
genotyping by PCR to amplify the WT Ehd1 allele, the deleted allele and/or the floxed allele. The lane labeled “no template” indicates a negative
control in the absence of DNA. (C) RT-PCR analysis was carried out using cDNA generated from mouse testes and primers specific for Ehd1 and
Ehd4. The primers are described in Methods.
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-/- at
post-natal days 10-12) (Table 1). These results indicated
that loss of EHD1 was partially lethal. Similar results
were seen after seven backcrosses (N7) to the FVB/NJ
strain (11% instead of the expected 25% were Ehd1
-/-;n
= 106 mice). The 129;B6 mixed strain was used in
further analyses unless specified.
The progeny from crosses of Ehd1
+/- mice were 49%
female and 51% male with twice as many Ehd1
+/- as
compared to WT mice, indicating normal gender
ratios and a lack of lethality when one copy of Ehd1
was present. A separate study was conducted where
t h eg e n o t y p eo fp u p st h a td i e df r o mu n k n o w nc a u s e s
between post-natal days 0 and 2 were examined.
Interestingly, 24 of 48 pups (50%) were Ehd1
-/- mice,
indicating a disproportionately higher frequency
(expected ~25%) of death among Ehd1
-/- mice at or
near birth.
Ehd1
-/- mice are smaller than WT mice and display
developmental defects
Ehd1
-/- mice that survived early neonatal lethality were
smaller than WT and Ehd1
+/- littermates from birth
(Figure 3A) to adulthood (Figure 3B). Both male and
female mice showed lower weights as compared to con-
trols (Figure 3C-D). In several cases, Ehd1
-/- females
displayed malocclusion (4/18, 22%) which required bi-
weekly incisor trimming into adulthood to prevent
death. A few animals were euthanized due to abnor-
mally small size and malnutrition at age 3-4 weeks inde-
pendent of incisor problems and several others perished
around this time due to unknown causes. A substantial
proportion of the surviving Ehd1
-/- animals displayed
gross ocular defects (~55% of eyes; n = 39 animals)
including anophthalmia (rare), microphthalmia (severe
cases exhibited closed eyelids), and congenital central
cataracts. The nature of eye developmental defects in
Ehd1
-/- mice is being pursued separately.
Ehd1
-/- male mice are infertile
Despite our repeated attempts to mate Ehd1
-/- mice, no
progeny were generated indicating the lack of fertility of
either one or both genders. Breeding Ehd1
+/- males with
Ehd1
-/- females gave rise to healthy pups (Table 1); only
29% (instead of 50% expected) of the mice that survived
to weaning age were Ehd1
-/-.F o ru n k n o w nr e a s o n s ,t h e
percentage of Ehd1
-/- mice surviving to weaning age
compared to Mendelian predictions were higher when
raised by an Ehd1
-/- dam versus an Ehd1
+/- dam. These
results further documented that Ehd1
-/- females were
Figure 2 EHD protein expression in adult WT, Ehd1
+/- and Ehd1
-/- male mice. Aliquots of 100 μg tissue lysates derived from seven month
old male mice were separated using 7.5% SDS-PAGE and Western blots were performed using antisera raised against EHD proteins as described
in Methods. The * denotes bands that bled through from the previous blot following stripping. Differential mobility of Hsc70 may represent
tissue specific isoforms. Relative molecular weight (MW) markers are indicated in kiloDaltons (kD). Hsc70 served as a loading control.
Table 1 Genotypes of pups obtained from Ehd1 mutant
mouse breeding schemes
Female Male WT
pups
Ehd1
+/-
pups
Ehd1
-/-
pups
Total
N* = 15 Ehd1
+/- Ehd1
+/- 82 (33%) 148 (59%) 19 (8%) 249
N* = 9 Ehd1
-/- Ehd1
+/- 0 44 (71%) 18 (29%) 62
N=8 W T Ehd1
-/- 000 0
N denotes the number of breeding pairs; * - some breeding pairs produced
multiple litters. % was calculated for each genotype based on total pups for
each breeding scheme. Ehd1
-/- males were bred for two months with two
females each.
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Page 4 of 19Figure 3 Ehd1
-/- mice are smaller than littermate controls and adult Ehd1
-/- males exhibit small testis. (A) Newborn pups and (B) seven
month old male mice were photographed to show the size of the Ehd1
-/- mice as compared to littermate controls. (C) Quantitative growth
curves of male and (D) female littermate control mice (n value shown for each). (E) Seminal vesicles and testis were dissected from mice
pictured in (B). Error bars represent standard deviation from the mean. ** indicates statistically significant using a two-sample t-test with a two-
tailed analysis (p < 0.05).
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Page 5 of 19fertile and the partial lethality in Ehd1-null mice (cur-
rently under investigation).
To test if Ehd1
-/- males were fertile, 8-week old males
were housed with two virgin adult females each. Despite
normal mating behavior, as determined by their ability
to mount females and give rise to a copulatory plug, no
Ehd1
-/- male mice were capable of siring offspring, indi-
cating that Ehd1
-/- males were infertile (Table 1).
Females used in these experiments were proven compe-
tent at being impregnated by other fertile males after
initial breeding with Ehd1
-/- males. The ability of eight
Ehd1
fl-Neo/fl-Neo breeding pairs to successfully produce
progeny provided evidence that the presence of loxP
sites in the targeted Ehd1 gene did not cause defects in
fertility or overall survival by influencing an untargeted
gene.
Previously, a C-terminal deletion of EHD1 in mice was
shown to have no effects in viability, growth or fertility
in 129/SvEv or Swiss Webster strains [27]. To determine
whether fertility defects in the Ehd1
-/- male mice were
influenced by genetic background, we crossed Ehd1
+/-
mice two times into the FVB/NJ strain (N2) and then
generated Ehd1
-/- mice. The resulting Ehd1
-/- male mice
were infertile while Ehd1
-/- female mice were fertile (n =
8). Further backcrossing revealed that Ehd1
-/- male
FVB/NJ strain (N7) mice were also infertile (n = 4),
indicating that loss of EHD1 leads to complete infertility
in male mice irrespective of strain.
Adult Ehd1
-/- male mice exhibit small testes
The raw weights of testes, spleen and kidneys of Ehd1
-/-
male mice at post-natal day 10 and 30 were not
statistically different from WT mice (Table 2). However,
f r o md a y4 2 ,t h et e s t e si nEhd1
-/- mice were smaller
than that of WT mice indicating the first delay in testes
development as determined by weight (Table 2, Figure
3E). Interestingly, the androgen-dependent seminal vesi-
cles were comparable in size between WT, Ehd1
+/- and
Ehd1
-/- mice (Table 2, Figure 3E) suggesting that hor-
mone levels were unaffected. Serum testosterone levels
of mice were variable; however, levels in Ehd1
-/- mice
were within a range comparable to those of WT and
Ehd1
+/- adult mice (824.5 ± 1364.0 ng/dL for WT [n =
3], 646.1 ± 859.4 ng/dL for Ehd1
+/- [n = 2] and 445.8 ±
511.4 for Ehd1
-/- [n = 11], ages 9-69 weeks, p > 0.05).
The small testis size phenotype was similar in N2 and
N7 FVB/NJ mice (data not shown).
EHD1 expression in post-natal mouse testis development
To assess the Ehd1 mRNA expression, in situ hybridiza-
tions were carried out in developing mouse testes. Ehd1
mRNA was expressed in most cells of the seminiferous
epithelia (Figure 4) including Sertoli cells (Figure 4, E’
inset).
To assess the EHD protein expression at early stages
of testis development, a Western blot was performed
(Figure 5A, upper panel). EHD1, EHD2 and EHD4 were
expressed in WT testis at days 10-42 while EHD3 levels
were relatively low. Interestingly, Ehd1
-/- testes displayed
an increase in EHD2, EHD3 and EHD4 expression at
day 30, 36 and 42. EHD1, EHD2 and EHD4 were also
expressed in an immortalized mouse Sertoli cell line
(TM4) as analyzed by Western blot (Figure 5A, lower
panel).
Table 2 Uncorrected organ weights and seminiferous tubule widths of WT and Ehd1
-/- male mice
Age Genotype Testes, mg Seminiferous Tubule Width, mm × 10
-1 Spleen, mg Kidneys, mg
Day 10 WT 8.9 ± 1.6 1.3 ± 0.1 21.8 ± 2.2 57.6 ± 9.3
Day 10 Ehd1
-/- 7.0 ± 1.0 1.2 ± 0.1 23.2 ± 8.5 46.5 ± 13.5
Day 30 WT 98.2 ± 10.7 2.9 ± 0.3 78.9 ± 13.9 238.2 ± 16.4
Day 30 Ehd1
-/- 90.5 ± 8.1 3.1 ± 0.2 90.0 ± 8.0 242.2 ± 39.7
Day 42 WT 172.7 ± 5.9* 3.6 ± 0.4 83.1 ± 10.2 358 ± 43.5
Day 42 Ehd1
-/- 127.7 ± 24.8* 3.6 ± 0.4 75.1 ± 6.7 324.7 ± 3.2
Weeks 9-11 WT 197.0 ± 17.5** n/a 63.7 ± 10.6 392.7 ± 30.6
Weeks 9-11 Ehd1
-/- 106.3 ± 17.1** n/a 69.0 ± 13.1 362 ± 15.9
Weeks 19-21 WT 227.0 ± 2.0** n/a 81.2 ± 7.0 442.4 ± 78.2
Weeks 19-21 Ehd1
-/- 136.7 ± 14.4** n/a 65.3 ± 11.6 341.3 ± 35.9
Weeks 61-69 WT 185.4 ± 31.3* n/a 70.2 ± 7.6 502.2 ± 38.2
Weeks 61-69 Ehd1
-/- 93.5 ± 6.9* n/a 60.2 ± 11.5 468.7 ± 136.7
Organs were dissected from euthanized mice and weighed. The testes weight represents both testis dissected from the scrotal sac, the seminiferous tubule
widths (n ≥ 20) were measured using ImageJ software http://rsbweb.nih.gov/ij/ to measure the smallest width of circular seminiferous tubules across the lumen
from light microscopy photographs of PAS-stained Bouin’s-fixed testis sections. The kidney weight represents both kidneys (n > 3 for each measurement). The
uncorrected seminal vesicle weights of 61-69 week old mice: WT = 569.9 ± 184.5 mg and Ehd1
-/- = 411.1 ± 89.3 mg (p > 0.05). Statistical analysis comparing the
raw data of each age-matched values between WT and Ehd1
-/- mice was determined using a two-sample t-test (* indicates p < 0.05 using one-tailed analysis, **
indicates p < 0.05 using two-tailed analysis).
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Page 6 of 19Figure 4 Ehd1 mRNA expression in post-natal mouse testis development. In situ hybridizations were performed as described in Methods on
WT (+/+) and Ehd1
-/- (-/-) testis sections prepared from post-natal day 10, 30, 36, 42 (P10-P42) and 10 month old (10 m) mice. Ehd1 mRNA
expression can be seen as red in dark-field images overlaid on bright-field images. Panels A’-I’ are higher magnifications of panels A-I,
respectively. The inset within E’ is an enlarged micrograph of the box in E’; arrows denote Sertoli cell nuclei. The scale bar in panel I is 100 μm
for B-J, 50 μm for A, C’-I’ and 25 μm for A’.
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immunohistochemistry was performed and revealed
EHD1 expression in most cells of the seminiferous
epithelium. At post-natal day 10, EHD1 was expressed
in the cytoplasm of both spermatogonia (filled
arrowheads) and Sertoli cells (open arrow-heads) at the
basement membrane with higher signals near the lateral
and apical surfaces of these cells (Figure 5B, panel A).
EHD1 expression was also seen around the nucleus of
spermatogonia (arrow) towards the lumen of
Figure 5 EHD protein expression and EHD1 localization during mouse testis development. (A, upper panel) Aliquots of 50 μg testis lysates
from post-natal day 10-42 mice were separated using 8% SDS-PAGE and a Western blot was performed using affinity purified antibodies raised
against EHD1 (described in Methods), followed by serial reprobing with antisera raised against EHD proteins as described previously [7]. b-Actin
served as a loading control. The * denotes bands that bled through from the previous blot. (A, lower panel) Aliquots of 20 μg immortalized
mouse TM4 Sertoli cell and mouse embryonic fibroblast (MEF, Ehd1
fl-Neo/fl-Neo) lysates were treated similarly except the membrane was probed
with antisera that recognize EHD1 and EHD4 followed by EHD2. (B, C) Immunohistochemistry was carried out to determine EHD1 localization in
day 10 and day 30 formalin-fixed testis sections from WT and Ehd1
-/- mice. EHD1 expression can be seen as brown staining; nuclei are counter-
stained with hematoxylin (blue). Panels A and B contained affinity purified anti-EHD1 primary antibodies while panels C and D lacked primary
antibodies (control). Insets in panel A are enlarged micrographs of the highlighted cells. Note: similar seminiferous tubules from adjacent
sections can be seen in A and C as well as B and D; denoted by asterisks (**). Sc - Sertoli cell, Sg - spermatogonia. Scale bar = 100 μm.
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EHD1 expression was absent in Ehd1
-/- testis (Figure
5B-C, panel B). At day 30, EHD1 was localized in the
cytoplasm of Sertoli cells and spermatogonia near the
base of seminiferous tubules. In addition, EHD1 was
expressed in pachytene spermatocytes, and round and
elongated spermatids (Figure 5C, panel A). Similar pat-
terns were observed in adult WT testis (not shown).
Ehd1
-/- mice show a range of abnormalities in
spermatogenesis
During spermatogenesis, spermatogonia undergo mitotic
divisions and differentiate into spermatocytes. Spermato-
cytes undergo two meiotic divisions, differentiate to
round spermatids that later form elongated spermatids
and are released from Sertoli cells during spermiation.
Progression of spermatogenesis is described using histol-
ogy of seminiferous tubule cross-sections in stages (I-
XII) that define the morphological development of germ
cells as a group [28,29]. The morphology of an indivi-
dual spermatid in spermiogenesis is described as a step
that is most easily followed by Periodic Acid-Schiff
(PAS)-stained acrosome formation and shape, or less
easily by assessing chromatin condensation and sperma-
tid head shape [28]. In order to discern initial lesions in
spermatogenesis, we carried out histological analyses of
testes in 10, 30, and 42 day old mice. At each age, the
average width of seminiferous tubules was comparable
between WT and Ehd1
-/- mice indicating that lumen
formation by the seminiferous epithelia was unaffected
in the absence of EHD1 (Table 2).
At post-natal day 10, the WT seminiferous tubules
predominantly contained Sertoli cells and some pachy-
tene spermatocytes, the most advanced germ cell type
seen at this age (Figure 6A). Spermatogonia were pre-
sent near the basement membrane and few apoptotic
features were seen (Figure 6B) [30]. Ehd1
-/- seminiferous
tubules were similar in appearance, also displaying some
apoptotic features in the lumen and near the basement
membrane (Figure 6C-D). There appeared to be a delay
in the normal maturation of spermatogonia and pachy-
tene spermatocytes in Ehd1
-/- as compared to WT mice
as analyzed by chromatin condensation and cell size. In
addition, some Ehd1
-/- seminiferous tubules contained a
greater number of apoptotic-like dense bodies than WT.
However, no major lesions were detected in the semini-
ferous tubules of Ehd1
-/- mice at day 10.
At day 30, normal spermatogenesis was apparent in
WT mice with well-organized germ cells typical of the
first wave of spermatogenesis. In general, Sertoli cells
were near the basement membrane while elongated
spermatids lined the lumen (Figure 7A, stage I-II) and
normal meiosis was observed in spermatocytes (Figure
7A, stage XII). Round spermatids displayed a round/
ovoid appearance until stage IX when the spermatid
head formed a dorsal and ventral surface with the acro-
some primarily on the dorsal surface of step 9 sperma-
tids (Figure 7B). In contrast, Ehd1
-/- seminiferous
tubules showed abnormal cells in meiosis (Figure 7C,
stage XII) and elongated spermatids that displayed
abnormal orientation, shape and chromatin condensa-
tion (Figure 7C, stage X). Some Ehd1
-/- seminiferous
tubules displayed a Sertoli cell only phenotype not seen
in the WT (Figure 7D) indicating a complete lack of
germ cells. Interestingly, a delay in the maturation of
elongated spermatids was observed with a mixture of
spermatids (step 9, 10, and 11) present in a seminiferous
tubule cross-section (Figure 7E). In WT mice, the PAS-
positive acrosomal cap of round spermatids covered
more than one third of the nucleus at stage VII with a
central acrosomal granule (Figure 7F). However, in
Ehd1
-/- mice, the acrosomal caps appeared abnormal
with asymmetric formations (Figure 7G) and punctate
appearances (Figure 7H). Neither the Ehd1
-/- nor the
WT epididymides contained spermatozoa at day 30,
confirming that these animals were in the initial waves
of spermatogenesis. Since round spermatids form prior
to day 30 (days 20-25), there may be lesions that were
not elucidated in the current study.
At day 42, the epididymides in WT mice contained
mature spermatozoa whereas Ehd1
-/- mice lacked sperm
(Figure 8); this defect continued into adulthood. To gain
further insights into abnormal spermatogenesis, we car-
ried out a detailed examination of 42 day old WT and
Ehd1
-/- mouse testes. WT mice displayed normal sper-
matogenesis where a single step of round and elongated
spermatids were supported by Sertoli cells in an
evenly spaced and orderly fashion in seminiferous tubule
cross-sections (Figure 9A-C). On the other hand, sper-
matogenesis only appeared normal prior to acrosome
formation in Ehd1
-/- mice. Several Ehd1
-/- seminiferous
tubule cross-sections exhibited a mixture of elongated
spermatids (Figure 9D, steps 9-11) as well as misaligned
elongated spermatids near the basement membrane,
suggesting Sertoli cell phagocytosis of step 16 sperma-
tids that failed to be released (Figure 9D-E, circles). In
late stage VIII, failure of spermiation and clumping of
spermatid heads was observed in addition to fusion of
large aggregates of residual bodies and cytoplasmic
lobes that contained clumped spermatids (Figure 9F-H,
arrows). In stage X, clumping of step 16 spermatids was
observed in membranous wheels and near the basement
membrane (Figure 9I). Step 16 spermatids were also
observed with their heads and tails fused; their cyto-
plasm failed to form cytoplasmic lobes and residual
bodies which are normally reabsorbed by Sertoli cells
(Figure 9J). Ehd1
-/- testis also showed abnormal step 11
spermatids (Figure 9J). Thus, our results demonstrate
Rainey et al. BMC Developmental Biology 2010, 10:37
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null testes.
To further characterize the defects in spermatogenesis
in Ehd1
-/- mice at the ultrastructural level, transmission
electron microscopy analyses were carried out on thin
sections of the testis. In stage VIII of WT testis (Figure
10A), elongated spermatids were found near the lumen
or in the lumen after spermiation (Figure 10B). Elon-
gated spermatids that had not spermiated maintained an
apical ectoplasmic specialization in contact with WT
Sertoli cells (Figure 10C). However, in late stage VIII of
Ehd1
-/- testis (Figure 10D), elongated spermatids
appeared in phagocytic, membranous wheels (Figure
10E, box). Upon closer examination, the phagocytic
wheel was encased by ectoplasmic specializations and
contained the nuclei, acrosomes and tails of elongated
spermatids (Figure 10F). Since proper function of the
Sertoli cells requires constant endocytic trafficking [31],
we surmise that EHD1-dependent endocytic recycling
and trafficking may be required for spermiation in mice.
Discussion
An earlier report of an Ehd1 knockout mouse indicated
no overt biological phenotype [27] which was surprising
given the in vitro cell biological evidence that supports
the critical roles of EHD proteins in endocytic recycling.
Here, we show that mice that completely lack EHD1
expression exhibit multiple overt phenotypes, consistent
w i t hac r i t i c a lr o l eo fE H D 1d u r i n gp r e -a n dp o s t - n a t a l
development and organ function. While reduction of
EHD1 in adult Ehd1
+/- mice was without detectable bio-
logical phenotypes, Ehd1
-/- mice survived at sub-Mende-
lian ratios and exhibited reduced body size. Ehd1
-/- mice
also showed higher early post-natal mortality and exhib-
ited two dramatic organ-specific phenotypes: marked
abnormalities in eye development (which is not pursued
further here) and male infertility (which is described in
detail here).
Spermatogenesis is a complex process in which diploid
spermatogonia develop into mature haploid spermatozoa
capable of fertilizing an ovum. In the testis, somatic
Figure 6 Post-natal day 10 tubule cross-sections of Ehd1
-/- male mouse testes show no major lesions. Day 10 testes were Bouin’s-fixed,
PAS-stained and hematoxylin-counter-stained to visualize the glycoproteins/acrosomes (pink) and nuclei (blue) and analyzed by light microscopy
using a 40× objective lens. Stages are labeled with Roman numerals. (A, B) The seminiferous tubules of WT (+/+) mice exhibit Sertoli cell nuclei
(Sc) near the basement membrane or toward the lumen, large spermatogonia (Sg) near the basement membrane, pachytene spermatocytes (P)
and occasional apoptotic-like (Ap) nuclei near the lumen. (C, D) The seminiferous tubules of Ehd1
-/- (-/-) mice are shown for comparison. Scale
bar in A = 50 μm for A-D.
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Page 10 of 19Figure 7 Abnormal acrosome and spermatid development in adolescent Ehd1
-/- male mice. Day 30 testes were Bouin’s-fixed, PAS-stained
and hematoxylin-counter-stained to visualize the glycoproteins/acrosomes (pink) and nuclei (blue) and analyzed by light microscopy using a 40×
objective lens (A-E) or 60× objective lens under oil immersion (F-H). Stages are labeled with Roman numerals. (A) WT (+/+) stage XII
seminiferous tubules with step 12 elongated spermatids and spermatocytes in meiosis I and II. (B) WT stage IX seminiferous tubules with step 9
spermatids. (C) Ehd1
-/- (-/-) stage XII seminiferous tubules display abnormal meiotic figures (Me). Stage X shows a mixture of spermatid steps with
abnormal orientation, shape and chromatin condensation (arrows). (D) An Ehd1
-/- seminiferous tubule exhibiting a Sertoli cell only (SCO)
phenotype and a (E) stage IX-XI seminiferous tubule containing step 9, 10 and 11 elongated spermatids (arrows). (F) Stage VII WT round
spermatids with PAS-positive acrosomal caps on developing step 7 round spermatids (arrows). (G-H) Ehd1
-/- step 7 round spermatids display
abnormal acrosomal caps (arrows), while others show abnormal displacement of the acrosomal granule, asymmetric formations and punctuate
appearances. Scale bar in A = 50 μm for A-E. Scale bar in F = 10 μm for F-H.
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cells [28]. During maturation, developing spermatids
remain attached to Sertoli cells through specialized
membrane structures. The final junction between sper-
matozoa and the Sertoli cell is an actin-based testis-spe-
cific adherens junction termed the apical ectoplasmic
specialization that forms in late stage VII and early stage
VIII of spermatogenesis [32,33]. Spermiation occurs at
late stage VIII when polarized spermatozoa are released
from Sertoli cells and enter the lumen.
The observed defects in spermatogenesis in Ehd1
-/-
male mice can explain their infertility. First, mature
spermatozoa are not found in the epididymides of
Ehd1
-/- males. Second, this is a direct result of the fail-
ure of spermiation. Third, spermiation failure can be
explained by abnormal clumping of elongated sperma-
tids in membranous wheels followed by phagocytosis by
Sertoli cells in stages VIII-X. Fourth, a delay in the pro-
gression of spermatogenesis results in a mixture of sper-
matid steps. Fifth, abnormal formation of the acrosomal
granule and cap of round spermatids was the earliest
lesion observed. Since only minor abnormalities were
detected in day 10 testes, these results implicate EHD1
in pre-pubertal development of the testis and suggest
that potential EHD1-dependent endocytic recycling
mechanisms in the haploid phase of spermatogenesis
may be required for normal acrosome development and
spermiation. Ultrastructural analyses of Ehd1
-/- mouse
testes further support these data.
Abnormal spermatogenesis and male sterility in
Ehd1
-/- mice indicate that either EHD2, EHD3 and
EHD4, are insufficient to compensate for the loss of
EHD1 or that EHD1 is uniquely important. Recent
immunohistochemical analysis suggested that EHD1 is
particularly highly expressed in elongated spermatids
[27] while our data suggests that Sertoli cells and sper-
matogonia also express EHD1 (Figure 5B-C, panel A).
Western blot analyses of an immortalized mouse Sertoli
cell line also indicated that EHD1, EHD2 and EHD4
proteins are expressed in Sertoli cells (Figure 5A, lower
panel) with lower/undetectable levels of EHD3. Avail-
ability of knockout models lacking the expression of the
other EHD family members (currently under develop-
ment in the laboratory) should help to unravel the
redundant versus unique EHD1 functions in spermato-
genesis. Analyses of Ehd4-null mice, in which both
males and females are fertile but male testis sizes are
~50% smaller than WT mice at day 31, indicate that
EHD4 is required for mice to attain normal pre-pubertal
testis size but is dispensable for male fertility (George et
al., manuscript accepted for publication).
How might the loss of endocytic recycling regulator
EHD1 lead to a block in spermatogenesis and spermia-
tion? The data described here indicate defects in sper-
miogenesis, a process where major restructuring of
spermatids occurs after the blood-testis barrier has
formed at the tight junctions of Sertoli cells. Germ cell
differentiation is coordinated by Sertoli cells and the
ectoplasmic specializations formed between Sertoli and
maturing germ cells in the adult animal. Once estab-
lished, these Sertoli-germ cell complexes move with
germ cells until spermiation occurs [34]. In Ehd1
-/-
mice, the acrosomal cap that associates with the junc-
tional complexes appear to develop abnormally. This
Figure 8 Ehd1
-/- male mice lack mature epididymal spermatozoa at day 42. Day 42 caput epididymides were Bouin’s-fixed, PAS-stained and
hematoxylin-counter-stained to visualize the glycoproteins (pink) and nuclei (blue) and analyzed by light microscopy using a 40× objective lens.
(A) WT (+/+) epididymides contained a columnar epithelial layer (E) with a smooth actin layer (arrow) beneath the long PAS-positive microvilli
that extend into the lumen. Mature spermatozoa (S) were present in the lumen. (B) The Ehd1
-/- (-/-) epididymides contained a few sloughed
round spermatids (Spt) and spermatocytes (Spc). Scale bar = 20 μm.
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-/- testis display a delay in spermatid development and abnormal spermatid clumping. Day 42 testes were Bouin’s-
fixed, PAS-stained and hematoxylin-counter-stained to visualize the glycoproteins/acrosomes (pink) and nuclei (blue) and analyzed by light
microscopy using a 40× objective lens. Stages are labeled with Roman numerals. (AC) WT (+/+) seminiferous tubules displayed evenly spaced
round and elongated spermatids. (D) Ehd1
-/- (-/-) seminiferous tubules contained step 9, 10, and 11 elongated spermatids (arrows) and
misoriented step 16 elongated spermatids near the basement membrane (circles) and (E) abnormal step 9 spermatids along with aggregates of
step 16 spermatids (circles). (F-H) Ehd1
-/- seminiferous tubules displayed membranous wheels or residual bodies (arrows, Rb) containing clumped
spermatids near the lumen in stage VIII, (I) misaligned spermatids (circle) and clumped step 16 spermatid nuclei (arrows) in stage X, (J) abnormal
step 11 spermatids in stage XI and step 16 spermatids clumping in membranous wheels in stage VIII. Scale bar = 50 μm.
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cell migration and thus result in clumping of spermatids
and failure of release. EHD1 expression in germ cells
and Sertoli cells indicate the abnormalities observed
could arise from defects in either cell type or both.
Endocytosis and recycling of integral membrane proteins
has recently emerged as an important regulator of sperma-
togenesis [31]. Since EHD proteins are known to regulate
endocytic recycling in other systems, we hypothesize a
role for EHD1 in endocytic recycling during spermatogen-
esis. Synchronous regulation of the actin-based ectoplas-
mic specializations and components of the blood-testis
barrier (gap junctions, adherens junctions and tight junc-
tions) co-ordinate spermatogenesis [33,35]; in addition,
these dynamic structures are regulated by hormones,
growth factors and cytokines to precisely control the
timing of the passage of developing germ cells via endocy-
tic recycling mechanisms [31,36]. Indeed, cytokines impli-
cated in transient physiological opening of the blood-testis
barrier have been shown to induce the internalization of
S e r t o l ic e l lj u n c t i o n a lp r o t e ins [36,37]. Notably, IL-1, a
cytokine implicated in the regulation of Sertoli-Sertoli cell
junctions [38], has been shown to up-regulate the expres-
sion of Ehd1 mRNA in other model cell systems [39].
How Sertoli cell and/or germ cell membrane proteins
involved in regulating ectoplasmic specializations are
recycled back to the cell membrane is completely
unknown. In this context, detailed future studies of the
trafficking of gap junction-, tight junction- and adherens
junction-associated proteins in the WT and Ehd1
-/- testis
as germ cells migrate from the basement membrane into
the adluminal compartments h o u l dp r o v i d eab e t t e r
Figure 10 Electron micrographs of day 45 seminiferous tubules reveal abnormal phagocytic membranous wheels in Ehd1
-/- mice. (A) In
WT mice, step 8 round spermatids were found in (B) early stage VIII seminiferous tubules that contained elongated spermatids in the process of
spermiation near the lumen with tails apparent after spermiation; box enlarged in (C). (C) A WT elongated spermatid prior to spermiation
maintains its ectoplasmic specializations (ES). (D) In Ehd1
-/- mice, step 8 round spermatids were found in (E) late stage VIII seminiferous tubules
that contained phagocytic membranous wheels engulfing elongated spermatids, their acrosomes and sperm tails; box enlarged in (F).
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matogenesis. Analyses of Sertoli-Sertoli and Sertoli-germ
cell interactions in vitro combined with Sertoli vs. germ
cell-specific EHD1 knockout should further help test these
models and ascertain the biochemical and cell biological
processes in spermatogenesis that are under EHD1
regulation.
What might lead to the small testes phenotype in the
Ehd1
-/- mice? Since elongated spermatids are phagocy-
tosed rather than spermiated in the Ehd1
-/- testes, there
are less germ cells in the seminiferous epithelium. The
presence of Sertoli cell-only seminiferous tubules in the
Ehd1
-/- testes indicates that progressive loss of germ
cells might occur and we have observed enhanced apop-
tosis in the Ehd1
-/- testes (data not shown). Since the
majority of adult testis weight is due to the presence of
germ cells in the seminiferous epithelium [40], germ cell
depletion due to phagocytosis, defects in differentiation
or increased apoptosis could be responsible for the
small testis phenotype.
At present, the developmental defects and growth
retardation seen in Ehd1
-/- mice is under investigation.
Our results contrast with the lack of observable pheno-
types in the EHD1 knockout mice previously described
[27]. The differences in strains (129Sv/Ev or Swiss Web-
ster versus mixed 129;B6) or the strategies used to
delete Ehd1 (part of exon 3 and 5 and all of exon 4 ver-
sus exon 1 in our studies) could have led to the differ-
ences observed. Whether the lack of a phenotype of
EHD1 deletion in the previous studies was a result of
full compensation by other EHD proteins or due to
expression of a truncated but functional EHD1 is not
known. An increase in the expression of other EHD
proteins is seen in the day 30-42 Ehd1
-/- testes described
here (Figure 5A, upper panel), yet the presence of ferti-
lity defects in the Ehd1
-/- mice indicate that this does
not compensate for loss of EHD1. In order to ensure
that N-terminally-truncated in-frame fragments of
EHD1 were not present in Ehd1
-/- mice, Western blots
of organ lysates were probed with an EHD1 antibody
that was raised against the C-terminal region. As
expected, we did not observe the ~61 kD full length
EHD1 in Ehd1
-/- mouse organs including the testis (Fig-
ure 2, Figure 5A). RT-PCR with two primer sets specific
to the C-terminal region of Ehd1 showed no amplifica-
tion of products using mRNA isolated from Ehd1
-/-
mouse testes when compared to expected products with
WT testes (Figure 1C). Furthermore, Ehd1
fl-Neo/fl-Neo
mice with loxP sites flanking the first exon of EHD1
were normal with respect to development, growth and
fertility. These results indicate that specific loss of
EHD1expression is responsible for the defects described.
Conclusions
Our analyses using an Ehd1
-/- mouse model with com-
plete loss of EHD1 expression demonstrates an impor-
tant role of this novel regulator of endocytic recycling in
mammalian development with a critical functional role
in spermatogenesis. This model provides a basis for
further studies to explore the physiological targets of
EHD1 and the biological processes regulated by this
protein as well as to explore how endocytic recycling
controls spermatogenesis. Thus our results indicate for
the first time, a crucial role of an endocytic recycling
regulatory protein EHD1 in spermatogenesis and pro-
vide the first evidence of a critical in vivo biological
function of a mammalian EHD protein family member.
Methods
Generation of Ehd1 gene-targeted mice
A conditional gene knockout targeting vector was gener-
ated using the “recombineering” method [41]. In brief,
we identified a BAC clone RPCI-22-373M7 containing
the mouse Ehd1 gene from the RPCI-22 mouse (129S6/
SvEvTac strain) BAC library high-density filters (Chil-
dren’s Hospital Oakland Research Institute, http://bac-
pac.chori.org). Using a series of “recombineering”
reactions, an ~11.7 kb fragment of the BAC DNA con-
taining the first and second exons of Ehd1 was retrieved
into a plasmid. Two loxP sites were introduced flanking
exon 1. The second loxP site was immediately preceded
by an engineered FRT-Neo-FRT selection cassette that
conferred G418 resistance in transfected ES cells. The
Neo gene could be removed from the gene locus with
the expression of FLP DNA recombinase, leaving behind
single FRT and loxP sequences thereby keeping the
alterations of the gene locus to a minimum. The recom-
bineering reagents (plasmids and bacterial strains) were
obtained from Dr. Neal G. Copeland at the National
Cancer Institute, Frederick, Maryland. PCR primer
sequences used to generate the targeting vector as well
as to generate probes for Southern hybridization are
listed (see Additional file 1).
Homologous recombination was carried out in mouse
embryonic stem cells to generate a targeted Ehd1 allele
using loxP sites flanking exon 1 of the Ehd1 gene. The
targeting vector was linearized with NotI and electropo-
rated into HM1, an ES cell line derived from the 129/
Ola mouse strain. We screened 95 clones after G418
and gancyclovir selection by Southern hybridization
using 5’ and 3’ external probes and identified 6 cor-
rectly-targeted clones. Two correctly-targeted ES cell
clones were injected into C57BL/6J blastocysts to yield
chimeric mice. One achieved germline transmission of
the targeted Ehd1 allele. Chimeric mice were mated
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sion of a targeted allele (Ehd1
flox/+) were selected.
Ehd1
flox/+ mice were mated with B6.FVB-Tg(EIIa-Cre)
C5379Lmgd/J mice expressing Cre recombinase from
the adenovirus EIIa promoter to generate heterozygote
mice (Ehd1
+/-). Ehd1
+/-;cre transgene-positive mice were
crossed to C57BL/6J mice to generate heterozygous
Ehd1-deleted, cre transgene-negative (Ehd1
+/-)m i c e ,
w h i c hw e r es u b s e q u e n t l yu sed to produce EHD1-defi-
cient mice (Ehd1
-/-). Alternatively, Ehd1
flox/+ mice were
mated with B6;SJL-Tg(ACTFLPe)9205Dym/J mice
expressing the enhanced FLP1 recombinase (FLPe) from
the human beta Actin (ACTB) promoter to remove the
FRT-flanked Neo gene. Ehd1
flox/+;FLPe transgene-posi-
tive mice were crossed to C57BL/6J mice to generate
heterozygous Ehd1-floxed, FLPe transgene-negative
(Ehd1
fl-Neo/+) mice. Crosses of Ehd1
fl-Neo/+mice gave rise
to homozygous floxed mice (Ehd1
fl-Neo/fl-Neo). These
mice were used in some experiments to confirm that
the observed phenotypes were due to loss of EHD1
expression and not due to insidious genetic aberrations
associated with the ES cell clone used to generate the
Ehd1 mutant mice. All mice were purchased from The
Jackson Laboratory.
Genotyping
Mouse tail DNA was extracted according to protocol
(Gentra Puregene Mouse Tail Kit, Qiagen catalog
#158267) and hydrated in water. PCR analysis of DNA
was carried out using three primers (primers1-3) in a
duplex PCR reaction as described (see Additional file 2).
PCR products were separated using 2% agarose gel elec-
trophoresis to determine the genotypes with various
Ehd1 alleles.
Reverse transcriptase polymerase chain reaction (RT-PCR)
Following euthanasia of mice, the testes were dissected
from the scrotal sac and flash-frozen in liquid nitrogen.
Total RNA was isolated according to the TRI Reagent
RT protocol (Molecular Research Center, Inc.) with sub-
stitution of chloroform for 4-bromoanisole during the
phase separation. RNA (1 μg) was denatured at 65°C for
5 min in the presence of 0.5 μg oligo(dT)15 primer (Pro-
m e g a ,M a d i s o n ,W I )a n d0 . 8 3m Md N T P s( N e wE n g -
land Biolabs, Ipswich, MA) in a total volume of 12 μL
of DEPC-treated water followed by quick annealing on
ice. The total reaction volume for reverse transcription
was brought to 20 μL reaction using 1× first strand buf-
fer (Invitrogen), 10 mM dithiothreitol (Invitrogen) and
50 units of Moloney murine leukemia virus reverse tran-
scriptase (Stratagene, La Jolla, CA) in DEPC-treated
water and placed at 42°C for 50 min. The reverse tran-
scriptase was heat-inactivated at 70°C for 10 min. The
resulting first strand cDNA was used as a template in a
PCR reaction as described (see Additional file 2) to
amplify a 394 bp product of exons 4 and 5 of Ehd1
using previously described primers (termed primersA
here) [27]; primers 4 and 5 (see Additional file 2) to
amplify a 261 bp product of exons 3 and 4 of Ehd1
(termed primersB); and the 3’ untranslated region of
Ehd4 was amplified using previously described primers
[27] to yield a 342 bp product (termed primersC here).
Animal husbandry and care
All experiments involving animals were approved by the
Institutional Animal Care and Use Committee and were
treated humanely in accordance with the institutional
guidelines and those in the National Institutes of Health
(NIH) Guide for the Care and Use of Laboratory Ani-
mals. For most studies, breeding of Ehd1
+/- mice was
used to generate WT (Ehd1
+/+), Ehd1
+/- and Ehd1
-/-
mice. In some cases, Ehd1
-/- females were bred with
Ehd1
+/- males to generate Ehd1
+/- and Ehd1
-/- mice. For
all breeding studies, Ehd1
-/- male mice (8-weeks of age)
were housed with two females for eight weeks to deter-
mine fertility.
Antibodies and Western blotting
Previously described rabbit anti-peptide antibodies
against human EHD proteins were utilized [7]. Similarly
generated antibodies against a synthetic EHD1 peptide
(amino acids 519-534: CADLPPHLVPPSKRRHE) was
cross-reactive with EHD1 and EHD4 and was used
either without purification to immuno-blot EHD1 and
EHD4 (Figure 2, Figure 5A, lower panel), or was Protein
G- purified for immuno-blotting (Figure 5A, upper
panel) and immunohistochemistry (Figure 5B-C). The
affinity purified antibodies preferentially recognize
EHD1 with low reactivity against EHD4 (Figure 5A,
upper panel). Tissue and cell lysates were prepared and
immuno-blotted as described [7], using 20-100 μg lysate
protein aliquots, primary antibodies at 1:2000 and Pro-
tein A-HRP conjugate (Invitrogen, #10-123) at 1:20,000
dilution. In Figure 2, the membrane was serially stripped
and reprobed beginning with antisera that recognize
EHD1 and EHD4, followed by EHD2, EHD3 and Hsc70
antibodies; blots shown have exposure times of less than
10 seconds, upon longer exposures, most EHD proteins
can be seen in each organ shown. In Figure 5A, upper
panel, blots shown have exposure times of 3 min for
EHD1, EHD2 and EHD4; exposure of 10 min for EHD3.
TM4 cells were obtained from ATCC (#CRL-1715).
Ehd1
fl-Neo/fl-Neo mouse embryonic fibroblasts were
obtained in-house using standard protocols [42].
Testis preparation and staging
Animals were euthanized, the testes and epididymides
were removed, weighed and immediately immersed in
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sively rinsed in water, stored in 50% ethanol overnight and
transferred to 70% ethanol overnight prior to embedding
in paraffin. Transverse sections (5 μm) were prepared on
glass slides, deparaffinized, and stained with Periodic
Acid-Schiff (PAS)-based stain and hematoxylin as a coun-
ter-stain according to the manufacturer’sp r o t o c o l( S i g m a -
Aldrich, St. Louis, MO, #395B). Staging of seminiferous
tubules was performed on light microscopy images.
Immunohistochemistry
Freshly removed testes were poked through the capsule
once at each pole with a 25 gauge, 5/8” needle to facili-
tate diffusion of the fixative, immersed overnight in 10%
neutral buffered formalin and transferred to 70% ethanol
prior to paraffin embedding. Transverse sections (5 μm)
were deparaffinized in xylene and rehydrated in graded
ethanols followed by PBS. For antigen retrieval, the
slides were boiled twice for 10 min in citrate-based anti-
gen unmasking solution (Vector Laboratories, Burlin-
game, CA, #H-3300) in a microwave. Endogenous
peroxidase was inactivated by a 15 min incubation in
3% hydrogen peroxide (Sigma-Aldrich, St. Louis, MO)
in PBS. Staining was carried out using the Zymed
Laboratories Histostain-SP Kit (Broad Spectrum, DAB,
Invitrogen, Carlsbad, CA, #95-9643). The affinity puri-
fied rabbit-anti-EHD1 primary antibodies were used at a
1:250 dilution in PBS/5% fetal bovine serum.
In situ hybridization
PCR amplification of the 3’ UTR of Ehd1 (nucleotides
1741-2220 [GenBank:NM_010119]) from WT mouse tes-
tis cDNA was carried out and cloned into pCR4-TOPO
(Invitrogen) and sequenced. To analyze Ehd1 mRNA
expression, [
35S] UTP-labeled riboprobes were generated.
The Ehd1 antisense riboprobe was synthesized using PstI-
digested Ehd1 DNA and T7 RNA polymerase (Promega,
Madison, WI). In situ hybridizations were performed
using the same hybridization and washing conditions as
described previously [43] on 10% neutral buffered forma-
lin-fixed testis sections that were paraffin-embedded and
mounted on StarFrost glass slides (Mercedes Medical, Sar-
asota, FL). The hybridized slides were soaked in Kodak
NTB-2 emulsion, dried and exposed for 8-10 days at 4°C.
Following development and fixation, the slides were coun-
ter-stained with hematoxylin. Bright- and dark-field
images were captured separately using a Nikon Eclipse
E600 microscope. Silver grains in the dark-field images
were pseudo-colored red using ADOBE Photoshop CS
and overlaid on corresponding bright-field images.
Serum testosterone measurements
Blood was collected from euthanized animals using
cardiac puncture and allowed to clot. Serum
testosterone levels were measured using a radioimmu-
noassay at the University of Virginia Center for
Research in Reproduction Ligand Assay and Analysis
Core.
Electron microscopy
Freshly removed testes were poked through the capsule
ten times at equidistant sites with a 25 gauge, 5/8” nee-
dle to facilitate diffusion of the fixative, immersed over-
night in 0.1 M Sorensen’s phosphate buffer containing
2% glutaraldehyde and 2% paraformaldehyde, washed in
0.1 M Sorensen’s phosphate buffer, post-fixed in 1%
OsO4 aqueous solution, washed in distilled water, dehy-
drated in a series of ethanol followed by propylene
oxide and embedded in Araldite. Sagittal cross-sections
of 60-90 nm thick were placed on 200 mesh uncoated
copper grids, stained with 2% uranyl acetate aqueous
and Reynold’s lead citrate and examined on a Philips
410LS transmission electron microscope operated at 80
kV. Digital images were recorded with an AMT digital
imaging system. Reagents were obtained from Electron
Microscopy Sciences.
Additional file 1: Primers for generating the Ehd1 targeting
construct and probes for Southern hybridization. A table containing
mouse primers.
Additional file 2: Primers for genotyping WT, Ehd1
+/-, Ehd1
-/-,
Ehd1
fl-Neo/+ and Ehd1
fl-Neo/fl-Neo mice and amplification of Ehd1 cDNA.
A table containing mouse primers for PCR and RT-PCR.
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